TCLRY yields 6700.00% · JNJ yields 2.13%● Live data
📍 TCLRY pulled ahead of the other in Year 1
Combined, TCLRY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TCLRY + JNJ for your $10,000?
Technicolor SA develops, creates, and delivers products and services for the media and entertainment sectors in France, the United Kingdom, rest of Europe, the United States, rest of Americas, and the Asia-Pacific. It operates through three segments: Technicolor Creative Studios, DVD Services, and Connected Home. The Technicolor Creative Studios segment offers high-end services to content creators, including visual effects and animation for features films, episodic series, advertising, video games, and other audiovisual content. The DVD Services segment replicates, packages, and distributes video game and music CD, DVD, and Blu-ray discs; and provides turnkey integrated supply-chain solutions comprising distribution, fulfillment, freight-brokerage, and transportation management services, as well as inventory management and related services. The Connected Home segment offers a portfolio of broadband and video customer premise equipment, including broadband modems and gateways, digital set-top boxes, and Internet of Things connected devices for Pay-TV operators and network service providers, as well as develops software solutions. The company was incorporated in 1985 and is headquartered in Paris, France.
Full TCLRY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.